Evidenciação de Riscos Sobre Pandemias no Formulário de Referência: uma Abordagem no Contexto da Covid-19.

This study sought to identify what motivated the publicly traded companies listed in B3 to disclose information about pandemic-related risk factors in their reference form. To this end, the companies that had or not addressed pandemics or epidemics as a risk to their business for 2019, 2020, and 2021 were analyzed through the Securities and Exchange Commission (SEC) website. Other relevant data were obtained through the Economatica database. Evidence of pandemic risk according to the analyzed companies was explained using variables related to their endogenous characteristics, determined based on previous studies and tested using univariate and multivariate statistical analysis by logistic regression; namely: audit, controlling shareholder, sector, size, internationalization, corporate governance, debt, and profitability. Multivariate analysis showed that size, audit, and corporate governance were significant to explain the evidence of risks in the reference form, corroborating univariate analysis. Only 6.99% of the companies showed pandemic-related risks for 2019, increasing to 75.34% for 2020 and 2021. This study verifies variables that explain the disclosure of risk factors regarding pandemics in an atypical context generated by COVID-19. [ABSTRACT FROM AUTHOR]